Assetmark, Inc Syneos Health, Inc. Transaction History

Assetmark, Inc

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$34.5 - $42.19 $38,019 - $46,493	-1,102 Reduced 58.03%	797 $33,000
Q1 2023 May 05, 2023	SELL	$33.32 - $40.98 $633 - $778	-19 Reduced 0.99%	1,899 $67,000
Q4 2022 Feb 10, 2023	SELL	$25.32 - $51.45 $3,316 - $6,739	-131 Reduced 6.39%	1,918 $70,000
Q3 2022 Nov 01, 2022	BUY	$46.5 - $79.14 $15,949 - $27,145	343 Added 20.11%	2,049 $97,000
Q2 2022 Aug 03, 2022	BUY	$63.06 - $84.75 $25,476 - $34,239	404 Added 31.03%	1,706 $122,000
Q1 2022 May 13, 2022	BUY	$74.15 - $99.36 $22,319 - $29,907	301 Added 30.07%	1,302 $105,000
Q3 2021 Nov 12, 2021	SELL	$84.7 - $96.31 $2,117 - $2,407	-25 Reduced 2.44%	1,001 $88,000
Q2 2021 Aug 16, 2021	SELL	$76.44 - $89.57 $6,803 - $7,971	-89 Reduced 7.98%	1,026 $92,000
Q1 2021 May 14, 2021	BUY	$67.36 - $80.76 $1,751 - $2,099	26 Added 2.39%	1,115 $85,000
Q4 2020 Feb 10, 2021	SELL	$53.08 - $69.86 $7,962 - $10,479	-150 Reduced 12.11%	1,089 $74,000
Q2 2020 Aug 11, 2020	BUY	$34.32 - $62.43 $4,290 - $7,803	125 Added 11.22%	1,239 $72,000
Q1 2020 May 12, 2020	SELL	$32.64 - $73.63 $5,548 - $12,517	-170 Reduced 13.24%	1,114 $44,000
Q3 2019 Nov 13, 2019	BUY	$46.64 - $55.39 $5,596 - $6,646	120 Added 10.31%	1,284 $68,000
Q1 2019 May 14, 2019	SELL	$36.91 - $55.7 $295 - $445	-8 Reduced 0.68%	1,164 $60,000
Q4 2018 Feb 13, 2019	SELL	$36.49 - $51.72 $3,430 - $4,861	-94 Reduced 7.42%	1,172 $46,000
Q2 2018 Aug 01, 2018	BUY	$35.0 - $48.9 $11,585 - $16,185	331 Added 35.4%	1,266 $59,000
Q1 2018 May 16, 2018	BUY	$31.7 - $44.1 $29,639 - $41,233	935 New	935 $33,000

731K

Ticker SYNH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,653,000
Description
Syneos Health, Inc. provides biopharmaceutical outsourcing solutions company in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers services for the development of diagnostics, drugs, biologics, de...

Get notified when there are updates to the investment portfolio of Assetmark, Inc, based on Form 13F filings with the SEC.

Stay updated on Assetmark, Inc with notifications on news.